MAPT and Mental deterioration: While amyloid pathology lies upstream of tau pathology (Oddo et al., 2003; Small and Duff, 2008), growing evidence indicates that tau pathology drives cognitive decline in AD (Murray et al., 2015), providing an explanation for the lack of connection between the staging of amyloid plaques and disease symptoms.